<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Eur J Med Res</journal-id>
      <journal-id journal-id-type="iso-abbrev">Eur. J. Med. Res</journal-id>
      <journal-title-group>
        <journal-title>European Journal of Medical Research</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0949-2321</issn>
      <issn pub-type="epub">2047-783X</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25199882</article-id>
      <article-id pub-id-type="pmc">4172948</article-id>
      <article-id pub-id-type="publisher-id">46</article-id>
      <article-id pub-id-type="doi">10.1186/s40001-014-0046-8</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A giant renal angiomyolipoma (AML) in a patient with septo-optic dysplasia (SOD)</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Cichocki</surname>
            <given-names>Marcin</given-names>
          </name>
          <address>
            <email>chilawert@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sosnowski</surname>
            <given-names>Marek</given-names>
          </name>
          <address>
            <email>mareksosnowski@poczta.onet.pl</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jablonowski</surname>
            <given-names>Zbigniew</given-names>
          </name>
          <address>
            <email>zb.jablonowski@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1">Clinic of Urology at Medical University, Military Medical Academy University Teaching Hospital-Central Veterans Hospital, &#x17B;eromskiego 113, 90-549 Lodz, Poland </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>9</day>
        <month>9</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>9</day>
        <month>9</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <volume>19</volume>
      <issue>1</issue>
      <elocation-id>46</elocation-id>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>5</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>7</day>
          <month>8</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Cichocki et al.; licensee BioMed Central Ltd. 2014</copyright-statement>
        <license license-type="open-access">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p>Angiomyolipoma (AML) is a rare benign renal tumor occurring in about 0.3 to 3% of the general population. Most frequently it takes the form of small single tumors occurring sporadically or accompanying tuberous sclerosis (Bourneville-Pringle disease). In some cases the tumor may reach a very large size and be a cause of various serious complications. This case description concerns a 26-year-old female patient, suffering from hypopituitarism, hypothyroidism and binocular blindness during the course of septo-optic dysplasia, in whom a giant, left renal AML was diagnosed and treated surgically. According to the authors&#x2019; knowledge this was the first reported case of a huge size AML in a patient with de Morsier syndrome.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Angiomyolipoma</kwd>
        <kwd>Hypopituitarism</kwd>
        <kwd>Septo-optic dysplasia</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2014</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Angiomyolipoma (AML) is a rare benign renal tumor histologically containing elements of smooth muscle, adipose tissue and blood vessels in various proportions. It occurs in 0.3 to 3% of the general population, four-fold more frequently in women and the peak of incidence falls between the 30th and 50th years of life [<xref ref-type="bibr" rid="CR1">1</xref>]. Most frequently (80%) these are small, singular tumors which occur unilaterally and occasionally. In the remaining cases they coexist with tuberous sclerosis (Bourneville-Pringle disease) and they may be bilateral and multiple and achieve significant sizes [<xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR3">3</xref>]. A tumor which is bigger than 10&#xA0;cm and affects a whole organ is considered a &#x2018;giant&#x2019; AML [<xref ref-type="bibr" rid="CR4">4</xref>]. Septo-optic dysplasia (de Morsier syndrome) is a very rare syndrome of congenital defects consisting of optic nerve hypoplasia, hypopituitarism, and agenesis of the septum pellucidum [<xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR6">6</xref>].</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>The patient, a 26-year-old woman with a diagnosis of hypopituitarism, hypothyroidism and binocular blindness in the course of septo-ocular dysplasia was admitted to the Clinic of Urology because of a large tumor of the left kidney. The patient was 139&#xA0;cm tall, weighed 52&#xA0;kg and her BMI amounted to 27&#xA0;kg/m<sup>2</sup>. Her blood pressure was 120/70&#xA0;mmHg, heart rate 70/minute, creatinine levels 66&#xA0;&#x3BC;mol/l, and her electrolytes, blood count and urinalysis were normal. The lesion had been diagnosed incidentally in another medical centre during investigation of persistent stomach ache with a suspicion of pyelonephritis. During case examination a perceptible mobile pathological resistance was reported on the left side of the stomach from the costal arch up to the iliac fossa. On abdominal ultrasonography (USG) examination, a large, intra-abdominal and left flank heterogeneous tumor with dimensions 170&#x2009;&#xD7;&#x2009;78&#xA0;mm, mostly hyperechogenic (consisting probably of adipose tissue with little vascularization observed in Doppler color) and probably coming out of the left kidney, was reported. The right kidney was 108&#xA0;mm long, with no urinary retention and no deposits. The diagnostics were extended by computer tomography (CT) angiography of the abdomen with contrast, in which the following was stated: numerous AMLs in the left kidney, the biggest coming out from its lower part and affecting the whole paranephric space and going down to the level of iliac fossa with dimensions of about 226&#x2009;&#xD7;&#x2009;95&#x2009;&#xD7;&#x2009;104&#xA0;mm. Except for this the other intra-abdominal organs revealed no abnormalities (Figures&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>, <xref rid="Fig2" ref-type="fig">2</xref>). The patient qualified for surgical treatment. The whole kidney with the entire tumor was removed (Figure&#xA0;<xref rid="Fig3" ref-type="fig">3</xref> and Figure&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>) by performing a median transperitoneal incision. Due to the risk of serious bleeding, the priority was to reach the renal vessels. The procedure was performed without any complications with the loss of 100&#xA0;ml of blood. Further recovery proceeded without any complications. Histopathological examination confirmed the diagnosis of AML.<fig id="Fig1"><label>Figure 1</label><caption><p>
<bold>Computer tomography (CT) angiography - visible tumor and pathological vessel.</bold>
</p></caption><graphic xlink:href="40001_2014_46_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Figure 2</label><caption><p>
<bold>A different scan with a visible tumor.</bold>
</p></caption><graphic xlink:href="40001_2014_46_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Figure 3</label><caption><p>
<bold>A post-surgical specimen with a visible fragment of ureter and healthy renal parenchyma.</bold>
</p></caption><graphic xlink:href="40001_2014_46_Fig3_HTML" id="MO3"/></fig><fig id="Fig4"><label>Figure 4</label><caption><p>
<bold>A post-surgical specimen with a visible fragment of healthy renal parenchyma.</bold>
</p></caption><graphic xlink:href="40001_2014_46_Fig4_HTML" id="MO4"/></fig></p>
    </sec>
    <sec id="Sec3" sec-type="discussion">
      <title>Discussion</title>
      <p>AML is one of the rarely occurring solid tumors of the kidney (2 to 6%). Most frequently they are diagnosed by chance during imaging examinations and they do not reach large sizes. They occur multifocally in about 1/3 and bilaterally in about 15% of all cases. They coexist with tuberous sclerosis (Bourneville-Pringle disease) with a frequency of about 20%. In such patients AML is diagnosed in 40 to 80% with a 2 to 3% risk of coexistence of renal cell carcinoma (RCC). AML has a mild nature and it does not produce metastases. Most frequently it proceeds asymptomatically. It may induce hematuria and uncharacteristic pain [<xref ref-type="bibr" rid="CR1">1</xref>-<xref ref-type="bibr" rid="CR3">3</xref>]. The most serious and dangerous complication for health from AML is spontaneous bleeding into the retroperitoneal space from pathological vessels, referred to as W&#xFC;nderlich syndrome [<xref ref-type="bibr" rid="CR7">7</xref>]. Diagnosis is based mainly on imaging examinations: USG and CT (presence of adipose tissue within the tumor mass of density of 10 Hounsfield units is a characteristic feature), magnetic resonance imaging (MRI), angiography. Tumors larger than 4&#xA0;cm are usually symptomatic and these are the tumors which require control every six months [<xref ref-type="bibr" rid="CR8">8</xref>]. The incidence of AML larger than 10&#xA0;cm in individuals without a diagnosis of tuberous sclerosis is extremely rare. The commonly applied methods of treatment include: cryoablation, embolization, tumorectomy, partial resection of the kidney, or nephrectomy. The choice and scope of treatment is determined by: tumor size, its vascularization, symptoms and comorbidities [<xref ref-type="bibr" rid="CR9">9</xref>]. Septo-optic dysplasia (de Morsier syndrome) is a syndrome of congenital defects which occurs at a frequency of 1:50,000 and which consists of: optic nerve hypoplasia, hypopituitarism, and agenesis of the septum pellucidum. Its etiology is multivariate and still not fully known. Recent reports claim a possible role of the <italic>HESX1</italic> gene which is responsible for the development of the pituitary and central parts of the brain. Boys fall ill from this syndrome just as often as girls [<xref ref-type="bibr" rid="CR10">10</xref>]. So far, an increased frequency of coexistence of renal carcinomas, including AML, has not been described. Herein, we have presented the first case of a large AML in a patient with de Morsier syndrome.</p>
    </sec>
    <sec id="Sec4" sec-type="conclusion">
      <title>Conclusions</title>
      <p>We have presented an extremely rare case of the coexistence of congenital defects in the form of septo-optic dysplasia associated with a giant renal AML. The patient required a precise diagnostic work-up and radical surgical treatment.</p>
    </sec>
    <sec id="Sec5">
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-list>
          <def-item>
            <term>AML</term>
            <def>
              <p>angiomyolipoma</p>
            </def>
          </def-item>
          <def-item>
            <term>BMI</term>
            <def>
              <p>body mass index</p>
            </def>
          </def-item>
          <def-item>
            <term>CT</term>
            <def>
              <p>computer tomography</p>
            </def>
          </def-item>
          <def-item>
            <term>MRI</term>
            <def>
              <p>magnetic resonance imaging</p>
            </def>
          </def-item>
          <def-item>
            <term>RCC</term>
            <def>
              <p>renal cell carcinoma</p>
            </def>
          </def-item>
          <def-item>
            <term>SOD</term>
            <def>
              <p>septo-optic dysplasia</p>
            </def>
          </def-item>
          <def-item>
            <term>USG</term>
            <def>
              <p>ultrasonography</p>
            </def>
          </def-item>
        </def-list>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>MC was a major contributor in writing the manuscript. MS critically revised the manuscript. ZJ reviewed the literature and gave final approval of the submitted version. All authors read and approved the final manuscript.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; information</bold>
        </p>
        <p>MC is the first author.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>We thank the editor and reviewers for providing medical writing services.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Steiner</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Goldman</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Fishman</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>Marshall</surname>
              <given-names>FF</given-names>
            </name>
          </person-group>
          <article-title>The natural history of renal angiomyolipoma</article-title>
          <source>J Urol</source>
          <year>1993</year>
          <volume>150</volume>
          <fpage>1782</fpage>
          <lpage>1786</lpage>
          <pub-id pub-id-type="pmid">8230504</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blute</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Malek</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Segura</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>Angiomyolipoma: clinical metamorphosis and concerns</article-title>
          <source>J Urol</source>
          <year>1988</year>
          <volume>139</volume>
          <issue>1</issue>
          <fpage>20</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="pmid">3336097</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lendvay</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Marshall</surname>
              <given-names>FF</given-names>
            </name>
          </person-group>
          <article-title>The tuberous sclerosis complex and its highly variable manifestations</article-title>
          <source>J Urol</source>
          <year>2003</year>
          <volume>169</volume>
          <issue>5</issue>
          <fpage>1635</fpage>
          <lpage>1642</lpage>
          <pub-id pub-id-type="doi">10.1097/01.ju.0000058253.40352.60</pub-id>
          <pub-id pub-id-type="pmid">12686801</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mitra</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jain</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kaza</surname>
              <given-names>RCM</given-names>
            </name>
          </person-group>
          <article-title>Giant angiomyolipoma of the kidney presenting as anaemia - a rare presentation</article-title>
          <source>Open J Urol</source>
          <year>2012</year>
          <volume>2</volume>
          <issue>No. 2</issue>
          <fpage>3</fpage>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Morsier</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>&#xC9;tudes sur les dysraphies, cr&#xE2;nioenc&#xE9;phaliques. III. Ag&#xE9;n&#xE9;sie du septum palludicum avec malformation du tractus optique. La dysplasie septo-optique</article-title>
          <source>Schweizer Archiv f&#xFC;r Neurologie und Psychiatrie, Zurich</source>
          <year>1956</year>
          <volume>77</volume>
          <fpage>267</fpage>
          <lpage>292</lpage>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kelberman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Dattani</surname>
              <given-names>MT</given-names>
            </name>
          </person-group>
          <article-title>Genetics of septo-optic dysplasia</article-title>
          <source>Pituitary</source>
          <year>2007</year>
          <volume>10</volume>
          <issue>4</issue>
          <fpage>393</fpage>
          <lpage>407</lpage>
          <pub-id pub-id-type="doi">10.1007/s11102-007-0055-5</pub-id>
          <pub-id pub-id-type="pmid">17587179</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Albi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Del Campo</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Tagarro</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>W&#xFC;nderlich&#x2019;s syndrome: causes, diagnosis and radiological management</article-title>
          <source>Clin Radiol</source>
          <year>2002</year>
          <volume>57</volume>
          <issue>9</issue>
          <fpage>840</fpage>
          <lpage>845</lpage>
          <pub-id pub-id-type="doi">10.1016/S0009-9260(02)90981-5</pub-id>
          <pub-id pub-id-type="pmid">12384111</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oesterling</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Fishman</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>Goldman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Marshall</surname>
              <given-names>FF</given-names>
            </name>
          </person-group>
          <article-title>The management of renal angiomyolipoma</article-title>
          <source>J Urol</source>
          <year>1986</year>
          <volume>135</volume>
          <fpage>1121</fpage>
          <lpage>1124</lpage>
          <pub-id pub-id-type="pmid">3520013</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dickinson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ruckle</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Beaghler</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hadley</surname>
              <given-names>HR</given-names>
            </name>
          </person-group>
          <article-title>Renal angiomyolipoma: optimal treatment based on size and symptoms</article-title>
          <source>Clin Nephrol</source>
          <year>1998</year>
          <volume>49</volume>
          <issue>5</issue>
          <fpage>281</fpage>
          <lpage>286</lpage>
          <pub-id pub-id-type="pmid">9617489</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Polizzi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pavone</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Iannetti</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Manfr&#xE9;</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ruggieri</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Septo-optic dysplasia complex: a heterogeneous malformation syndrome</article-title>
          <source>Pediatr Neurol</source>
          <year>2006</year>
          <volume>34</volume>
          <fpage>66</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2005.07.004</pub-id>
          <pub-id pub-id-type="pmid">16376284</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
